ReviveMed is a biotechnology company based in Cambridge, Massachusetts, specializing in the integration of artificial intelligence (AI) with metabolomics—the comprehensive study of small molecules, or metabolites, within biological systems. Founded in 2017 by Dr. Leila Pirhaji, a computational biologist and tech entrepreneur, the company aims to revolutionize precision medicine by leveraging AI to interpret complex metabolomic data.